Sensei biotherapeutics appoints maura gillison, m.d., ph.d., and richard ulevitch, ph.d.

Boston and rockville, md., may 05, 2021 (globe newswire) -- sensei biotherapeutics, inc. (nasdaq: snse), a  clinical-stage immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, today announced the appointments of maura gillison, m.d., ph.d., professor of medicine, thoracic/head and neck medical oncology at md anderson cancer center, and richard ulevitch, ph.d., professor of immunology and chairman emeritus at the scripps research institute, to its immuno-oncology advisory board.
SNSE Ratings Summary
SNSE Quant Ranking